Free Trial

Pacific Biosciences of California (PACB) Short Interest Ratio & Short Volume

Pacific Biosciences of California logo
$1.28 +0.05 (+3.63%)
As of 03:55 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Pacific Biosciences of California Short Interest Data

Pacific Biosciences of California (PACB) has a short interest of 39.64 million shares, representing 13.55% of the float (the number of shares available for trading by the public). This marks a -23.80% decrease in short interest from the previous month. The short interest ratio (days to cover) is 4.5, indicating that it would take 4.5 days of the average trading volume of 9.78 million shares to cover all short positions.

Current Short Interest
39,640,000 shares
Previous Short Interest
52,020,000 shares
Change Vs. Previous Month
-23.80%
Dollar Volume Sold Short
$47.57 million
Short Interest Ratio
4.5 Days to Cover
Last Record Date
June 15, 2025
Outstanding Shares
300,080,000 shares
Short Percent of Float
13.55%
Today's Trading Volume
15,920,484 shares
Average Trading Volume
9,776,617 shares
Today's Volume Vs. Average
163%
Short Selling Pacific Biosciences of California?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Pacific Biosciences of California and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

PACB Short Interest Over Time

PACB Days to Cover Over Time

PACB Percentage of Float Shorted Over Time

Pacific Biosciences of California Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/15/202539,640,000 shares $47.57 million -23.8%13.5%4.5 $1.20
5/31/202552,020,000 shares $51.37 million -8.7%19.5%6 $0.99
5/15/202556,950,000 shares $60.37 million +15.7%21.3%6.5 $1.06
4/30/202549,210,000 shares $54.62 million +4.3%N/A4.8 $1.11
4/15/202547,200,000 shares $59.94 million -13.6%17.7%4.4 $1.27
3/31/202554,600,000 shares $64.43 million +2.2%20.4%4.7 $1.18
3/15/202553,410,000 shares $65.16 million -13.8%20.0%4.9 $1.22
2/28/202561,980,000 shares $89.87 million -7.1%23.2%5.5 $1.45
2/15/202566,690,000 shares $123.38 million +10.4%25.0%6.1 $1.85
1/31/202560,400,000 shares $93.02 million -0.2%N/A5.7 $1.54
1/15/202560,540,000 shares $105.64 million +6.5%N/A6 $1.75
12/31/202456,850,000 shares $104.04 million +7.1%N/A5.8 $1.83
12/15/202453,060,000 shares $104.00 million -2.4%N/A5.7 $1.96
11/30/202454,380,000 shares $103.87 million +4.3%N/A5.6 $1.91
11/15/202452,140,000 shares $83.16 million +3.4%N/A5.5 $1.60
10/31/202450,410,000 shares $109.39 million +3.9%N/A5.8 $2.17
10/15/202448,540,000 shares $101.93 million -6.0%N/A5.9 $2.10
9/30/202451,640,000 shares $87.79 million +11.0%N/A5.7 $1.70
9/15/202446,530,000 shares $84.22 million -23.8%N/A4.9 $1.81
8/31/202461,030,000 shares $83.61 million +1.8%N/A6.8 $1.37
8/15/202459,960,000 shares $101.33 million +5.0%N/A6.8 $1.69
7/31/202457,100,000 shares $117.63 million -7.4%N/A5.9 $2.06
7/15/202461,680,000 shares $99.92 million +9.2%N/A6.2 $1.62
6/30/202456,470,000 shares $77.36 million +3.5%N/A5.3 $1.37
6/15/202454,570,000 shares $96.04 million +0.6%N/A5.3 $1.76
5/31/202454,250,000 shares $97.11 million -4.1%N/A5.2 $1.79
5/15/202456,580,000 shares $121.36 million +7.1%N/A5.2 $2.15
4/30/202452,820,000 shares $87.15 million +8.9%N/A5.1 $1.65
4/15/202448,520,000 shares $137.55 million -1.1%N/A5 $2.84
3/31/202449,050,000 shares $183.94 million +7.6%N/A5.6 $3.75
3/15/202445,570,000 shares $172.71 million +4.7%N/A5.4 $3.79
2/29/202443,540,000 shares $240.78 million +7.8%N/A5.3 $5.53
2/15/202440,380,000 shares $269.33 million +18.1%N/A5.4 $6.67
1/31/202434,190,000 shares $222.58 million -5.0%N/A5.1 $6.51
1/15/202436,000,000 shares $241.56 million -4.7%N/A5.6 $6.71
12/31/202337,780,000 shares $370.62 million +8.3%N/A6.7 $9.81
12/15/202334,890,000 shares $329.36 million +4.4%N/A6.7 $9.44
11/30/202333,430,000 shares $283.49 million -14.8%N/A7 $8.48
11/15/202339,230,000 shares $306.39 million +11.7%N/A8.5 $7.81
10/31/202335,120,000 shares $217.04 million -6.9%N/A8.1 $6.18
Trump set to Boost Social Security Checks by 400%? (Ad)

If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President Trump's Executive Order #14196 could not only save Social Security from collapse... ...but potentially increase benefits by up to 400%, according to legendary investor Louis Navellier.

Click here to watch the full presentation before it's too late.
10/15/202337,740,000 shares $301.17 million +14.1%N/A9.6 $7.98
9/30/202333,070,000 shares $276.13 million -2.2%N/A8.6 $8.35
9/15/202333,820,000 shares $352.40 million +2.3%N/A9.4 $10.42
8/31/202333,060,000 shares $372.92 million +5.3%N/A9.3 $11.28
8/15/202331,390,000 shares $352.20 million +10.6%N/A8.3 $11.22
7/31/202328,390,000 shares $375.03 million -7.6%N/A7.7 $13.21
7/15/202330,710,000 shares $421.96 million -2.7%N/A8.6 $13.74
6/30/202331,550,000 shares $419.62 million +25.3%N/A8.8 $13.30
6/15/202325,190,000 shares $335.28 million -1.0%N/A6.7 $13.31
5/31/202325,440,000 shares $314.95 million +5.2%N/A6.7 $12.38
5/15/202324,180,000 shares $300.80 million -5.0%N/A6.6 $12.44
4/30/202325,440,000 shares $269.66 million -6.4%N/A6.7 $10.60
4/15/202327,180,000 shares $304.42 million +8.3%N/A6.6 $11.20
3/31/202325,100,000 shares $290.66 million -4.5%N/A5.8 $11.58
3/15/202326,280,000 shares $238.10 million +14.2%N/A6.2 $9.06
2/28/202323,020,000 shares $209.02 million +8.4%N/A5.6 $9.08
2/15/202321,240,000 shares $235.55 million -5.6%N/A5.3 $11.09
1/31/202322,490,000 shares $249.41 million -7.1%N/A5 $11.09
1/15/202324,200,000 shares $265.23 million -1.9%N/A4.9 $10.96
12/30/202224,670,000 shares $201.80 million +8.1%N/A5.1 $8.18
12/15/202222,820,000 shares $206.75 million +3.8%N/A4.4 $9.06
11/30/202221,990,000 shares $236.39 million -9.1%N/A3.9 $10.75
11/15/202224,190,000 shares $270.93 million +4.1%N/A4 $11.20
10/31/202223,240,000 shares $196.15 million -3.0%N/A3 $8.44
10/15/202223,950,000 shares $146.10 million -5.3%N/A3.1 $6.10
9/30/202225,290,000 shares $146.81 million -16.6%N/A3.3 $5.81
9/15/202230,310,000 shares $200.35 million +4.8%N/A3.8 $6.61
8/31/202228,930,000 shares $169.53 million -11.6%N/A3.6 $5.86
8/15/202232,720,000 shares $273.54 million -7.5%N/A3.9 $8.36
7/31/202235,360,000 shares $154.52 million -1.9%N/A5.1 $4.37
7/15/202236,030,000 shares $152.77 million -12.2%N/A5.1 $4.24
6/30/202241,020,000 shares $181.31 million +7.9%N/A5.7 $4.42
6/15/202238,010,000 shares $162.68 million +10.6%N/A5.3 $4.28
5/31/202234,370,000 shares $193.50 million +3.0%N/A5 $5.63
5/15/202233,370,000 shares $194.88 million +1.2%N/A5.2 $5.84
4/30/202232,960,000 shares $208.97 million +8.8%N/A5.5 $6.34
4/15/202230,290,000 shares $228.39 million -2.8%N/A5.2 $7.54
3/31/202231,170,000 shares $283.65 million +1.3%N/A5.6 $9.10
3/15/202230,760,000 shares $281.76 million +3.5%N/A6.3 $9.16
2/28/202229,710,000 shares $354.14 million +8.5%N/A6.6 $11.92
2/15/202227,390,000 shares $311.70 million +3.1%N/A6.3 $11.38
1/31/202226,580,000 shares $297.16 million +22.9%N/A7.1 $11.18
1/15/202221,630,000 shares $268.86 million +8.6%N/A6.9 $12.43
12/31/202119,910,000 shares $407.36 million -1.6%N/A7.8 $20.46
12/15/202120,230,000 shares $444.86 million +19.2%N/A9 $21.99
11/30/202116,970,000 shares $393.87 million -5.1%N/A8.5 $23.21
11/15/202117,890,000 shares $477.66 million +0.9%N/A9.6 $26.70
10/29/202117,730,000 shares $469.49 million +14.2%9.3%9.9 $26.48
10/15/202115,520,000 shares $378.53 million +9.3%8.2%8.5 $24.39
9/30/202114,200,000 shares $362.81 million +9.3%7.5%7.4 $25.55
Trump set to Boost Social Security Checks by 400%? (Ad)

If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President Trump's Executive Order #14196 could not only save Social Security from collapse... ...but potentially increase benefits by up to 400%, according to legendary investor Louis Navellier.

Click here to watch the full presentation before it's too late.
9/15/202112,990,000 shares $359.04 million +2.4%6.8%6.6 $27.64
8/31/202112,690,000 shares $397.32 million +8.8%6.7%6.4 $31.31
8/13/202111,660,000 shares $343.62 million -2.1%6.1%5.7 $29.47
7/30/202111,910,000 shares $382.91 million -2.6%6.3%5.2 $32.15
7/15/202112,230,000 shares $330.21 million -10.5%6.5%5 $27.00
6/30/202113,660,000 shares $477.69 million -0.8%7.2%5.5 $34.97
6/15/202113,770,000 shares $385.84 million +0.8%7.3%5.2 $28.02
5/28/202113,660,000 shares $369.50 million -2.6%7.2%4.7 $27.05
5/14/202114,030,000 shares $312.87 million +3.1%N/A3.9 $22.30
4/30/202113,610,000 shares $455.66 million +15.9%N/A3.2 $33.48
4/15/202111,740,000 shares $382.14 million -8.9%N/A2.8 $32.55
3/31/202112,890,000 shares $386.06 million +12.4%N/A2.7 $29.95
3/15/202111,470,000 shares $388.72 million +28.9%N/A2.1 $33.89
2/26/20218,900,000 shares $277.46 million -8.3%N/A1.6 $31.18
2/12/20219,710,000 shares $496.67 million -25.3%N/A1.9 $51.15
1/29/202113,000,000 shares $445.64 million -1.2%N/A2.7 $34.28
1/15/202113,160,000 shares $496.40 million -15.7%N/A2.7 $37.72
12/31/202015,610,000 shares $411.32 million +30.7%N/A3.2 $26.35
12/15/202011,940,000 shares $249.55 million -12.8%N/A2.6 $20.90
11/30/202013,690,000 shares $211.24 million -5.1%N/A3.1 $15.43
11/15/202014,430,000 shares $241.56 million -3.7%N/A3.4 $16.74
10/30/202014,990,000 shares $200.27 million -14.0%N/A3.5 $13.36
10/15/202017,420,000 shares $243.18 million +0.2%N/A4.5 $13.96
9/30/202017,380,000 shares $171.54 million +0.9%N/A5.3 $9.87
9/15/202017,230,000 shares $126.12 million +3.8%N/A7 $7.32
8/31/202016,600,000 shares $109.56 million -4.8%N/A8.3 $6.60
8/14/202017,430,000 shares $100.22 million +0.1%12.3%9.9 $5.75
7/31/202017,410,000 shares $64.94 million -2.4%12.3%13.7 $3.73
7/15/202017,830,000 shares $74.35 million -0.1%12.6%14.2 $4.17

PACB Short Interest - Frequently Asked Questions

What is Pacific Biosciences of California's current short interest?

Short interest is the volume of Pacific Biosciences of California shares that have been sold short but have not yet been closed out or covered. As of June 15th, investors have sold 39,640,000 shares of PACB short. 13.55% of Pacific Biosciences of California's shares are currently sold short. Learn More on Pacific Biosciences of California's current short interest.

What is a good short interest ratio for Pacific Biosciences of California?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PACB shares currently have a short interest ratio of 4.0. Learn More on Pacific Biosciences of California's short interest ratio.

Which institutional investors are shorting Pacific Biosciences of California?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Pacific Biosciences of California: Walleye Trading LLC, Simplex Trading LLC, and National Bank of Canada FI. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Pacific Biosciences of California?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 13.55% of Pacific Biosciences of California's floating shares are currently sold short.

Is Pacific Biosciences of California's short interest increasing or decreasing?

Pacific Biosciences of California saw a decrease in short interest in the month of June. As of June 15th, there was short interest totaling 39,640,000 shares, a decrease of 23.8% from the previous total of 52,020,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Pacific Biosciences of California's short interest compare to its competitors?

13.55% of Pacific Biosciences of California's shares are currently sold short. Here is how the short interest of companies compare to Pacific Biosciences of California: Harvard Bioscience, Inc. (7.56%), Thermo Fisher Scientific Inc. (1.30%), Agilent Technologies, Inc. (1.45%), Mettler-Toledo International, Inc. (3.01%), Waters Corporation (2.90%), Illumina, Inc. (4.09%), Bio-Techne Corp (4.08%), Charles River Laboratories International, Inc. (5.38%), Bio-Rad Laboratories, Inc. (4.83%), Bruker Corporation (9.59%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks.

What does it mean to sell short Pacific Biosciences of California stock?

Short selling PACB is an investing strategy that aims to generate trading profit from Pacific Biosciences of California as its price is falling. PACB shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Pacific Biosciences of California?

A short squeeze for Pacific Biosciences of California occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PACB, which in turn drives the price of the stock up even further.

How often is Pacific Biosciences of California's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PACB, twice per month. The most recent reporting period available is June, 15 2025.




This page (NASDAQ:PACB) was last updated on 7/1/2025 by MarketBeat.com Staff
From Our Partners